New TomTec rises from ashes
TomTec's 3-D ultrasound technology lives on. The defunct ultrasound developer has sold rights to the technology to a group of managers from the company's German subsidiary in Munich. The executives have formed a new company, TomTec GmbH, with the
TomTec's 3-D ultrasound technology lives on. The defunct ultrasound developer has sold rights to the technology to a group of managers from the company's German subsidiary in Munich. The executives have formed a new company, TomTec GmbH, with the intention of carrying forward TomTec's 3-D legacy.
TomTec Imaging Systems closed its doors last month after its venture-capital backers pulled out of the company and its management failed to find new funding (SCAN 6/11/97). In liquidating the company, TomTec's management said it intended to sell off the company's assets.
The Munich-based management team includes Bernhard Mumm, Frank Schlau, and Ulrich Haupt, who intend to resume on a worldwide basis all of the 3-D business activities and end-user relationships of TomTec Imaging Systems. The Munich facility had been the headquarters of TomTec predecessor Tomographic Technologies, which was merged with Prism Imaging/Freeland Systems to create TomTec Imaging Systems in late 1993.
All of TomTec's 3-D products, including TomTec Echo-Scan, EchoView, and Compact 3-D, will continue to be produced and marketed. TomTec GmbH will also continue the development of Windows NT-based clinical procedure and visualization packages for cardiac and general imaging applications.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.
